STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells - PubMed (original) (raw)
STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells
Laura Passerini et al. Int Immunol. 2008 Mar.
Abstract
Forkhead box P3 (FOXP3) is considered a specific marker for CD4(+)CD25(+) regulatory T (Treg) cells, but increasing evidence suggests that human CD4(+)CD25(-) effector T (Teff) cells can transiently express FOXP3 upon activation. We demonstrate that the signal transducer and activator of transcription 5 (STAT5)-signaling cytokines, IL-2, IL-15 and to a lesser extent IL-7, induce FOXP3 up-regulation in vitro in activated human Teff cells. In contrast, cytokines which do not activate STAT5, such as IL-4 or transforming growth factor-beta alone, do not directly induce FOXP3 expression in activated Teff cells. Moreover, expression of a constitutively active form of STAT5a is sufficient to induce FOXP3 expression in Teff cells. Expression of FOXP3 in activated Teff cells requires both TCR-mediated activation and endogenous IL-2, but is not dependent on cell division and does not induce suppressive function. The presence of STAT5-activating cytokines is also required to maintain high FOXP3 expression and suppressive activity of Treg cells in vitro. These data indicate that activation of STAT5 sustains FOXP3 expression in both Treg and Teff cells and contribute to our understanding of how cytokines affect the expression of FOXP3.
Similar articles
- The Jak inhibitor CP-690,550 preserves the function of CD4CD25FoxP3 regulatory T cells and inhibits effector T cells.
Sewgobind VD, Quaedackers ME, van der Laan LJ, Kraaijeveld R, Korevaar SS, Chan G, Weimar W, Baan CC. Sewgobind VD, et al. Am J Transplant. 2010 Aug;10(8):1785-95. doi: 10.1111/j.1600-6143.2010.03200.x. Epub 2010 Jul 12. Am J Transplant. 2010. PMID: 20626385 Clinical Trial. - Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis.
Murawski MR, Litherland SA, Clare-Salzler MJ, Davoodi-Semiromi A. Murawski MR, et al. Ann N Y Acad Sci. 2006 Oct;1079:198-204. doi: 10.1196/annals.1375.031. Ann N Y Acad Sci. 2006. PMID: 17130555 - CCL11 increases the proportion of CD4+CD25+Foxp3+ Treg cells and the production of IL‑2 and TGF‑β by CD4+ T cells via the STAT5 signaling pathway.
Wang R, Huang K. Wang R, et al. Mol Med Rep. 2020 Jun;21(6):2522-2532. doi: 10.3892/mmr.2020.11049. Epub 2020 Apr 1. Mol Med Rep. 2020. PMID: 32323817 Free PMC article. - The phenotypic and functional consequences of tumour necrosis factor receptor type 2 expression on CD4(+) FoxP3(+) regulatory T cells.
Chen X, Oppenheim JJ. Chen X, et al. Immunology. 2011 Aug;133(4):426-33. doi: 10.1111/j.1365-2567.2011.03460.x. Epub 2011 Jun 2. Immunology. 2011. PMID: 21631498 Free PMC article. Review. - Is FOXP3 a bona fide marker for human regulatory T cells?
Roncarolo MG, Gregori S. Roncarolo MG, et al. Eur J Immunol. 2008 Apr;38(4):925-7. doi: 10.1002/eji.200838168. Eur J Immunol. 2008. PMID: 18395862 Review.
Cited by
- Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity.
Sogkas G, Atschekzei F, Adriawan IR, Dubrowinskaja N, Witte T, Schmidt RE. Sogkas G, et al. Cell Mol Immunol. 2021 May;18(5):1122-1140. doi: 10.1038/s41423-020-00626-z. Epub 2021 Apr 1. Cell Mol Immunol. 2021. PMID: 33795850 Free PMC article. Review. - Long-lasting immune responses 4 years after GAD-alum treatment in children with type 1 diabetes.
Axelsson S, Chéramy M, Hjorth M, Pihl M, Akerman L, Martinuzzi E, Mallone R, Ludvigsson J, Casas R. Axelsson S, et al. PLoS One. 2011;6(12):e29008. doi: 10.1371/journal.pone.0029008. Epub 2011 Dec 12. PLoS One. 2011. PMID: 22174945 Free PMC article. - Current Strategies in Treating Cytokine Release Syndrome Triggered by Coronavirus SARS-CoV-2.
Wang LG, Wang L. Wang LG, et al. Immunotargets Ther. 2022 May 18;11:23-35. doi: 10.2147/ITT.S360151. eCollection 2022. Immunotargets Ther. 2022. PMID: 35611161 Free PMC article. Review. - Tipping the balance in autoimmunity: are regulatory t cells the cause, the cure, or both?
Hardtke-Wolenski M, Landwehr-Kenzel S. Hardtke-Wolenski M, et al. Mol Cell Pediatr. 2024 Mar 20;11(1):3. doi: 10.1186/s40348-024-00176-8. Mol Cell Pediatr. 2024. PMID: 38507159 Free PMC article. Review. - IL-7R signaling in regulatory T cells maintains peripheral and allograft tolerance in mice.
Schmaler M, Broggi MA, Lagarde N, Stöcklin BF, King CG, Finke D, Rossi SW. Schmaler M, et al. Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):13330-5. doi: 10.1073/pnas.1510045112. Epub 2015 Oct 8. Proc Natl Acad Sci U S A. 2015. PMID: 26450881 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous